Skip to main content

Emergencies After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

  • Chapter
  • First Online:

Abstract

Since its first description by Spratt in 1980 (Cancer Res 40:253–255, 1980) and further refinement by Sugarbaker, cytoreductive surgery complemented by hyperthermic intraperitoneal chemotherapy (HIPEC) (Ann Surg 221:29–42, 1995) has gained popularity and has entered mainstream care for multiple peritoneal surface malignancies including pseudomyxoma peritonei, primary peritoneal carcinomatosis, mesothelioma, peritoneal colorectal carcinomatosis (Int J Colorectal Dis 29:895–898, 2014), peritoneal gastric carcinomatosis (Vet Anaesth Analg 41:386–392, 2014), and more recently ovarian cancer. As the number of HIPEC procedures increases, surgeons are now increasingly facing complications, often in an emergency setting.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Spratt JS, Adcock RA, Sherrill W, Travathen S. Hyperthermic peritoneal perfusion system in canines. Cancer Res. 1980;40:253–5.

    CAS  PubMed  Google Scholar 

  2. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221:29–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Vallicelli C, Cavaliere D, Catena F, et al. Management of peritoneal carcinomatosis from colorectal cancer: review of the literature. Int J Colorectal Dis. 2014;29:895–8.

    Article  PubMed  Google Scholar 

  4. Rudolff AS, Moens YP, Driessen B, Ambrisko TD. Comparison of an infrared anaesthetic agent analyser (Datex-Ohmeda) with refractometry for measurement of isoflurane, sevoflurane and desflurane concentrations. Vet Anaesth Analg. 2014;41:386–92.

    Article  CAS  PubMed  Google Scholar 

  5. Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27:6237–42.

    Article  PubMed  Google Scholar 

  6. Levine EA, Stewart JH, Shen P, et al. Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg. 2014;218:573–85.

    Article  PubMed  Google Scholar 

  7. Baratti D, Kusamura S, Mingrone E, et al. Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg. 2012;256:334–41.

    Article  PubMed  Google Scholar 

  8. Youssef H, Newman C, Chandrakumaran K, et al. Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin. Dis Colon Rectum. 2011;54:293–9.

    Article  PubMed  Google Scholar 

  9. Verwaal VJ, van Tinteren H, Ruth SV, Zoetmulder FA. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol. 2004;85:61–7.

    Article  PubMed  Google Scholar 

  10. Simkens GA, van Oudheusden TR, Luyer MD, et al. Serious postoperative complications affect early recurrence after cytoreductive surgery and HIPEC for colorectal peritoneal carcinomatosis. Ann Surg Oncol. 2015;22:2656–62.

    Article  PubMed  Google Scholar 

  11. Simkens GA, van Oudheusden TR, Braam HJ, et al. Treatment-related mortality after cytoreductive surgery and HIPEC in patients with colorectal peritoneal carcinomatosis is underestimated by conventional parameters. Ann Surg Oncol. 2015;23:99–105.

    Article  PubMed  Google Scholar 

  12. Jaehne J. Cytoreductive procedures-strategies to reduce postoperative morbidity and management of surgical complications with special emphasis on anastomotic leaks. J Surg Oncol. 2009;100:302–5.

    Article  PubMed  Google Scholar 

  13. Mizumoto A, Canbay E, Hirano M, et al. Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a single institution in Japan. Gastroenterol Res Pract. 2012;2012:836425.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Rueth NM, Murray SE, Huddleston SJ, et al. Severe electrolyte disturbances after hyperthermic intraperitoneal chemotherapy: oxaliplatin versus mitomycin C. Ann Surg Oncol. 2011;18:174–80.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Byrne Lee M.D., F.A.C.S. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Dumitra, S., Lee, B. (2017). Emergencies After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). In: Fong, Y., Kauffmann, R., Marcinkowski, E., Singh, G., Schoellhammer, H. (eds) Surgical Emergencies in the Cancer Patient. Springer, Cham. https://doi.org/10.1007/978-3-319-44025-5_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-44025-5_28

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-44023-1

  • Online ISBN: 978-3-319-44025-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics